Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Non-Current Assets (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Non-Current Assets for 5 consecutive years, with $1.1 million as the latest value for Q3 2020.

  • Quarterly Non-Current Assets fell 90.07% to $1.1 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $5.6 million through Sep 2020, down 86.78% year-over-year, with the annual reading at $152000.0 for FY2019, 97.15% down from the prior year.
  • Non-Current Assets for Q3 2020 was $1.1 million at Forte Biosciences, up from $167000.0 in the prior quarter.
  • The five-year high for Non-Current Assets was $13.0 million in Q1 2019, with the low at $152000.0 in Q4 2019.
  • Average Non-Current Assets over 5 years is $4.3 million, with a median of $3.4 million recorded in 2016.
  • The sharpest move saw Non-Current Assets soared 704.38% in 2019, then crashed 98.66% in 2020.
  • Over 5 years, Non-Current Assets stood at $2.9 million in 2016, then crashed by 50.03% to $1.4 million in 2017, then skyrocketed by 269.32% to $5.3 million in 2018, then tumbled by 97.15% to $152000.0 in 2019, then skyrocketed by 632.24% to $1.1 million in 2020.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $1.1 million, $167000.0, and $4.1 million for Q3 2020, Q2 2020, and Q1 2020 respectively.